Acosta Andres M, Al Rasheed Mohamed R Haroon, Xu Haoliang, Salibay Christine, Pins Michael R
Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Department of Pathology, Chicago Medical School, North Chicago, IL, USA.
APMIS. 2018 Apr;126(4):353-356. doi: 10.1111/apm.12826.
Sebaceous carcinoma of the breast (SCB) is a rare variant of ductal carcinoma arising within the mammary gland and containing at least 50% of malignant cells with sebaceous differentiation. Only 11 cases that adjust to the criteria delineated in the WHO classification have been published in the English literature, to the best of our knowledge. Here, we present the first SCB arising in the context of a deleterious BRCA2 mutation, focusing on the histopathologic and immunohistochemical features of this exceedingly rare tumor.
乳腺皮脂腺癌(SCB)是一种起源于乳腺的导管癌罕见变体,含有至少50%具有皮脂腺分化的恶性细胞。据我们所知,英文文献中仅发表了11例符合世界卫生组织分类标准的病例。在此,我们报告首例发生于有害BRCA2突变背景下的SCB,重点关注这种极其罕见肿瘤的组织病理学和免疫组化特征。